Literature DB >> 24746740

Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment?

Jianzhi Ren1, Aiguo Sha2, Dongmei Han2, Ping Li2, Jie Geng2, Chaihui Ma2.   

Abstract

OBJECTIVE: To evaluate the effects of a prolonged duration of gonadotropin-releasing hormone agonist (GnRH-a) in pituitary down-regulation for controlled ovarian hyperstimulation (COH) on the live-birth rate in nonendometriotic women undergoing in vitro fertilization and embryo transfer (IVF-ET).
DESIGN: Retrospective cohort study.
SETTING: University-affiliated hospital. PATIENT(S): Normogonadotropic women undergoing IVF. INTERVENTION(S): Three hundred seventy-eight patients receiving a prolonged pituitary down-regulation with GnRH-a before ovarian stimulation and 422 patients receiving a GnRH-a long protocol. MAIN OUTCOME MEASURE(S): Live-birth rate per fresh ET. RESULT(S): In comparison with the long protocol, the prolonged down-regulation protocol required a higher total dose of gonadotropins. A lower serum luteinizing hormone (LH) level on the starting day of gonadotropin and the day of human chorionic gonadotropin (hCG) and a fewer number of oocytes and embryos were observed in the prolonged down-regulation protocol. However, the duration of stimulation and number of high-quality embryos were comparable between the two groups. A statistically significantly higher implantation rate (50.27% vs. 39.69%), clinical pregnancy rate (64.02% vs. 56.87%) and live-birth rate per fresh transfer cycle (55.56% vs. 45.73%) were observed in the prolonged protocol. CONCLUSION(S): Prolonged down-regulation in a GnRH-a protocol might increase the live-birth rates in normogonadotropic women.
Copyright © 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Controlled ovarian hyperstimulation; gonadotropin releasing hormone agonist (GnRH-a); in vitro fertilization

Mesh:

Substances:

Year:  2014        PMID: 24746740     DOI: 10.1016/j.fertnstert.2014.03.030

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  24 in total

1.  Differential response of AMH to GnRH agonist among individuals: the effect on ovarian stimulation outcomes.

Authors:  Jiali Cai; Lanlan Liu; Juan Zheng; Ling Zhang; Xiaoming Jiang; Ping Li; Aiguo Sha; Jianzhi Ren
Journal:  J Assist Reprod Genet       Date:  2017-12-21       Impact factor: 3.412

2.  Clinical and perinatal outcomes of fresh single-blastocyst-transfer cycles under an early follicular phase prolonged protocol according to day of trigger estradiol levels.

Authors:  Yingfen Ying; Xiaosheng Lu; Huina Zhang; Samuel Kofi Arhin; Xiaohong Hou; Zefan Wang; Han Wu; Jieqiang Lu; Yunbing Tang
Journal:  PeerJ       Date:  2021-07-26       Impact factor: 2.984

3.  Prolonged pituitary down-regulation with full-dose of gonadotropin-releasing hormone agonist in different menstrual cycles: a retrospective cohort study.

Authors:  Yingfen Ying; Tanchu Yang; Huina Zhang; Chang Liu; Junzhao Zhao
Journal:  PeerJ       Date:  2019-04-29       Impact factor: 2.984

4.  Efficacy and Safety of In Vitro Fertilization (IVF)/Intracytoplasmic Sperm Injection (ICSI) Among Patients with Endometriosis After a Shortened Protocol of Long-Term Pituitary Downregulation.

Authors:  Huijuan Kong; Zhiqin Bu; Yihong Guo; Fang Wang; Hao Shi; Linli Hu; Yingpu Sun
Journal:  Med Sci Monit       Date:  2019-06-12

5.  Mild starting dosage ovarian stimulation combined with a modified prolonged GnRH-a protocol improved IVF/ICSI outcomes in normal ovarian responders.

Authors:  Li-Feng Tian; Jun Tan; Yang Zou; Qiong Su; You Li; Ding-Fei Xu; Qiong-Fang Wu
Journal:  Arch Med Sci       Date:  2019-05-16       Impact factor: 3.318

6.  Efficacies of different ovarian hyperstimulation protocols in poor ovarian responders classified by the POSEIDON criteria.

Authors:  Fei Li; Tian Ye; Huijuan Kong; Jing Li; Linli Hu; HaiXia Jin; Yingchun Su; Gang Li
Journal:  Aging (Albany NY)       Date:  2020-05-29       Impact factor: 5.682

7.  Prosaposin in seminal plasma on the day of oocyte retrieval is associated with normal fertilization and embryo development in in vitro fertilization cycles.

Authors:  Chun Xu; Jiali Cai; Lanlan Liu; Jianzhi Ren
Journal:  PeerJ       Date:  2019-12-11       Impact factor: 2.984

8.  Analysis of the Number of Euploid Embryos in Preimplantation Genetic Testing Cycles With Early-Follicular Phase Long-Acting Gonadotropin-Releasing Hormone Agonist Long Protocol.

Authors:  Gang Li; Yifang Wu; Wenbin Niu; Jiawei Xu; Linli Hu; Hao Shi; Yingpu Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-21       Impact factor: 5.555

9.  Comparison Between PPOS and GnRHa-Long Protocol in Clinical Outcome with the First IVF/ICSI Cycle: A Randomized Clinical Trial.

Authors:  Qianwen Xi; Yu Tao; Meiting Qiu; Yun Wang; Yanping Kuang
Journal:  Clin Epidemiol       Date:  2020-03-03       Impact factor: 4.790

10.  Impacts of medroxyprogesterone acetate on oocytes and embryos: matched case-control study in women with stage III-IV ovarian endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization.

Authors:  Haiyan Guo; Hongyuan Gao; Jianghui Li; Yanyan Cong; Qiuju Chen; Yun Wang; Qianqian Zhu; Qifeng Lyu; Ling Wu; Weiran Chai; Yanping Kuang
Journal:  Ann Transl Med       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.